1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6A3B6816C9F4520E400258789006888CE
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/A3B6816C9F4520E400258789006888CE?OpenDocument
18
19OpenDocument
2018.208.126.232
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Medical Education

Document Excerpt: How Pharma is Utilizing Social Media for Delivering Medical Education

DB Image

ID: MD-805


Features:

18 Info Graphics

10 Data Graphics

100+ Metrics

11 Narratives


Published: 2021


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".


To return to the study abstract to purchase the full study - click here.

This excerpt includes research findings and metrics from document #5705 "How Pharma is Utilizing Social Media for Delivering Medical Education"

Industries Profiled:
Pharmaceutical; Health Care; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Consulting; Biopharmaceutical


Companies Profiled:
AbbVie; Merck; Astellas; Merck Serono; Bayer; Eisai; Teva Pharmaceutical Industries Ltd; Roche; GlaxoSmithKline ; AstraZeneca; Biogen; bioMerieux; Allergan; Sanofi Genzyme; Otsuka Pharmaceutical Development & Commercialization; Inc. (OPDC); Sandoz; Baxter BioScience; Ipsen; Merz Pharma; MEDiSTRAVA; Kyowa Kirin; CSL Behring; Grunethal; GRAIL; Apellis Pharmaceuticals; Rhythm Pharmaceuticals; Taiho Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.